Cost-Utility of Cancer Therapies - the 'Cost' of Different Utility Generation Strategies.

Meads, D M; McCabe, C; Hulme, C T; Edlin, R; Kharroubi, S A; Browne, C; Ford, H; Dunn, J; Marshall, A

Meads, D M; McCabe, C; Hulme, C T; Edlin, R; Kharroubi, S A; Browne, C; Ford, H; Dunn, J; Marshall, A.

Afiliación

Meads DM; University of Leeds, Leeds, UK.
McCabe C; University of Alberta, Edmonton, AB, Canada.
Hulme CT; University of Leeds, Leeds, UK.
Edlin R; University of Auckland, Auckland, New Zealand.
Kharroubi SA; University of York, York, UK.
Browne C; Evidera, London, UK.
Ford H; Addenbrooke's Hospital, Cambridge, UK.
Dunn J; University of Warwick, Coventry, UK.
Marshall A; University of Warwick, Coventry, UK.

Value Health ; 17(7): A327, 2014 Nov.

Article en En | MEDLINE | ID: mdl-27200549

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google